Evidence map›Paper›PMID 32956848›Full record

ArticleMolecular metabolism2020

Changes in circulating miRNA19a-3p precede insulin resistance programmed by intra-uterine growth retardation in mice.

Sarah Saget, Rong Cong, Lyvianne Decourtye, Marie-Laure Endale, Laetitia Martinerie, Clémence Girardet, Claire Perret, Maud Clemessy, Patricia Leneuve, Laetitia Dinard and 9 more

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Sarah SagetSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Rong CongSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Lyvianne DecourtyeSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Marie-Laure EndaleIHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Laetitia MartinerieUniversité Paris Saclay, INSERM, UMR_S1185, Faculté de Médecine Paris Sud, F-94270, Le Kremlin-Bicêtre, France.
Clémence GirardetSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Claire PerretIHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France; Sorbonne Université, INSERM, UMR_S1166, F-75013, Paris, France.
Maud ClemessySorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Patricia LeneuveSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Laetitia DinardSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France.
Badreddine Mohand OumoussaSorbonne Université, Inserm, UMS 29 Omique, Plateforme Post-Génomique de la Pitié-Salpêtrière, F-75013, Paris, France.
Dominique FarabosSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; Département de Métabolomique Clinique, Hôpital Saint Antoine, AP-HP, F-75012, Paris, France.
Antonin LamazièreSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; Département de Métabolomique Clinique, Hôpital Saint Antoine, AP-HP, F-75012, Paris, France.
Marc LombèsUniversité Paris Saclay, INSERM, UMR_S1185, Faculté de Médecine Paris Sud, F-94270, Le Kremlin-Bicêtre, France.
Marthe MoldesSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Bruno FèveSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France; Department of Endocrinology, Saint Antoine Hospital, AP-HP, F-75012, Paris, France.
David TregouetIHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France; Sorbonne Université, INSERM, UMR_S1166, F-75013, Paris, France; INSERM, UMR_S 1219, Bordeaux Population Health Research Center, F-33076, Bordeaux, France.
Yves Le BoucSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France.
Laurent KappelerSorbonne Université, INSERM, Centre de Recherche St Antoine, CRSA, F-75012, Paris, France; IHU-ICAN Institute of Cardiometabolism and Nutrition, Paris, France. Electronic address: laurent.kappeler@inserm.fr.
Inserm · FRFondation pour l’innovation en Cadiométabolisme et Nutrition · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIndividuals born with intrauterine growth retardation (IUGR) are more prone to cardio-metabolic diseases as adults, and environmental changes during the perinatal period have been identified as potentially crucial factors. We have studied in a preclinical model early-onset molecular alterations present before the development of a clinical phenotype.

methodsWe used a preclinical mouse model of induced IUGR, in which we modulated the nutrition of the pups during the suckling period, to modify their susceptibility to cardio-metabolic diseases in adulthood.

resultsMice born with IUGR that were overfed (IUGR-O) during lactation rapidly developed obesity, hepatic steatosis and insulin resistance, by three months of age, whereas those subjected to nutrition restriction during lactation (IUGR-R) remained permanently thin and highly sensitive to insulin. Mice born with IUGR and fed normally during lactation (IUGR-N) presented an intermediate phenotype and developed insulin resistance by 12 months of age. Molecular alterations to the insulin signaling pathway with an early onset were observed in the livers of adult IUGR-N mice, nine months before the appearance of insulin resistance. The implication of epigenetic changes was revealed by ChIP sequencing, with both posttranslational H3K4me3 histone modifications and microRNAs involved.

conclusionsThese two changes lead to the coherent regulation of insulin signaling, with a decrease in Akt gene transcription associated with an increase in the translation of its inhibitor, Pten. Moreover, we found that the levels of the implicated miRNA19a-3p also decreased in the blood of young adult IUGR mice nine months before the appearance of insulin resistance, suggesting a possible role for this miRNA as an early circulating biomarker of metabolic fate of potential use for precision medicine.

Indexed as

AnimalsCell-Free Nucleic AcidsDisease Models, AnimalFemaleFetal Growth RetardationHistonesInsulinInsulin-Like Growth Factor IInsulin ResistanceMaleMiceMice, 129 StrainMice, Inbred C57BLMicroRNAsSignal TransductionCell-Free Nucleic Acidshistone H3 trimethyl Lys4HistonesInsulinInsulin-Like Growth Factor IMicroRNAsMIRN19a microRNA, mouseBiomarkerDOHaDEpigeneticsHistone modificationsIUGRmicroRNA19aNutrition

Identifiers

PMID32956848
PMCPMC7559280
OpenAlexW3087704549

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.